NCT06725927

Vaccination Against Influenza Pre-discharge in Heart Failure

Vaccination Against Influenza Pre-discharge in Patients Hospitalized Due to Heart Failure

• Status: Active Not Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Wroclaw Medical University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

In patients with heart failure (HF), influenza vaccination should be considered to prevent HF hospitalizations. However, vaccination rates among patients with HF are low, in part because of subjective but common concerns about whether patients with such severe disease should be vaccinated. In this randomized, open-label study, we will investigate whether influenza vaccination before discharge in patients stabilized after cardiac decompensation is safe and improves outcomes over a 6-month follow-up period.

Conditions

• Heart Failure

Interventions

Type	Name	Description
BIOLOGICAL	Influenza vaccination	Influenza vaccination pre-discharge in patients hospitalized due to heart failure exacerbation

Timeline

• Start date: 2024-12-31
• Primary completion: 2025-11-30
• Completion: 2025-12-01
• First posted: 2024-12-10
• Last updated: 2025-07-23

Locations

1 site across 1 country: Poland